Illuminations Strategy Group’s Post

🧐📊 Allis.Health's #Analyst Note: #DigitalDiabetes #Partnership #Ecosystems: Introducing the Ecosystem Types & Builders Take a glimpse into a short extract, offering valuable insights from a 10-minute Analyst deep dive! Some of the market insights ✔️ Digital diabetes partnership ecosystems bring together different healthcare stakeholders together, offering a holistic care experience with integrated and innovative solutions for the people living with diabetes, and growth opportunities for the businesses ✔️ These ecosystems drive innovation and business growth in the market segment ✔️ What are the four types of digital diabetes partnership ecosystems? Who are some of the key builders in each ecosystem? ✔️ In what ways do partnerships in the #CommercialEcosystem aim to support the distribution and sales of diabetes platform offerings? Major players: Virta Health, Omada Health, Castell, Aetna, a CVS Health Company ✔️ How is Health2Sync 智抗糖 expanding its footprint globally and regionally in APAC? What types of partnership ecosystems is the company focusing on? Deep dive further:  * What are the characteristics of the #ecosystems: service, industry, and device? * Who are the top players in these ecosystems? * How does Abbott leverage device partnership ecosystems to expand its product outreach in different regions and enhance service areas in digital diabetes? * What partnerships is Omada Health strategically prioritizing? To watch the complete Analyst Note 🌟 Subscribe to Allis.Health or Reach out to us at hello@allis.health to schedule a demo session and start a complimentary trial. #marketinsights #analystviews #digitalhealth #digitaldiabetes 

Dive into our latest blog to discover how advanced #segmentation is revolutionising #pharma engagement. Learn how integrating behavioural and psychographic insights with traditional data enhances understanding of healthcare professionals (HCPs), patients, and payers. Explore how our enhanced segmentation framework facilitates personalised interactions and drives more effective marketing strategies.

Dive into our latest blog to discover how advanced #segmentation is revolutionising #pharma engagement. Learn how integrating behavioural and psychographic insights with traditional data enhances understanding of healthcare professionals (HCPs), patients, and payers. Explore how our enhanced segmentation framework facilitates personalised interactions and drives more effective marketing strategies.

Patient engagement series - 2 of 4 A Call for a new approach: The case for Dynamic Patient Profiling Patient centricity has become a driver of patient outcomes and therefore of strategic decisions, as patients now play a bigger role in their healthcare journey. This creates a need for Dynamic Patient Profiling, which focuses on the unique characteristics and behaviors of patients. Traditional segmentation is static, assuming patients assigned to a particular segment remain in that segment. But patients have changing needs and behaviors across their dynamic journey, which involves multiple touchpoints with various stakeholders such as caregivers, payers, and digital health tools. Traditional segmentation also skews to the average, limiting the ability to identify and target sub-segments that may have unique needs or preferences. Additionally, traditional segmentation is often not actionable or linked to strategy, limiting its effectiveness in driving engagement and improving outcomes. Insights gained from segmentation may be interesting, but do not necessarily translate into meaningful actions or improvements in patient outcomes. There is often a gap between insights and action, as the insights may not be linked to specific engagement strategies or tactics that can drive behavior change or improve outcomes. Additionally, there are exciting new opportunities due to newly available data. With advances in technology and data analytics, we can now access a broader range of data sets to inform patient segmentation strategies. more on how IQVIA can help next week.... Emily Tower Angela Radcliffe Brittany Wolf Gianares, MPH Annlouise Regina Assaf Madeline Rosato Roma Tretiak Kristina Jones Rosemarie Sellati Alex Eifler Harnish Naik, PhD Melissa Connolly Matthew Smith Brian Lovinguth Gopa Radhakrishnan, MPH Valerie Eng Broderick Jones Nitin PatelLaila R.Abir Yamak, Ph.D. Tyson Kuehl Elyse Muñoz, PhD Murray Aitken Harnish Naik, PhD Todd Culpepper Jeff Borman, MBA Reiko Sato Richard R. Hallquist #patientadvocacy #patientengagement #patientcentricity

The following two segments are the third and fourth:- 3- Lifestyle and Behavior-Based Segmentation: Consider lifestyle factors and patient behaviors when segmenting the market. This can include health-conscious individuals who are proactively managing their well-being, adhering to preventive measures, or seeking holistic healthcare solutions. 4- Treatment Journey Segmentation: Segment the market based on the patient's treatment journey, including diagnosis, treatment options, and post-treatment care. This can help identify specific needs and challenges at each stage, enabling targeted interventions and support. #consultations #PharmaConsultation

As much as it pains me to say it... Your evidence probably won't get you very far, unless you can also demonstrate ROI. Many of us working in digital health may have been motivated about doing good in the world - and I'd like to believe our clients are too - but the truth is that that pesky question is lurking in all sales conversations: 💸 what's the ROI? Because of this, I've seen some digital health companies jump to ROI first - before they establish any other evidence. It's a gamble that might pay off - but it's not a gamble I'd suggest taking. Here's the way I see it: 🏆 Maximizing ROI is your ultimate goal 📈 Your ROI is probably driven by having an actual impact on the condition(s) your interventions are targeting ➡ so maximizing outcomes is key. 👩💻 Maximizing outcomes isn't just about increasing the effect size, but maximizing how many people benefit from your solution. So that means optimizing engagement - and specifically how many users engage with your product in a beneficial way. See what I did there? It's back to the three previous steps! Use Step 1 to help maximize engagement. Steps 2 and 3 help to assess and maximize your outcomes. And now I'd say you're ready to invest in HEOR work, feeling good that the ROI you get at the end of it will be impressive. I realise this is a lot to ask - who has years to wait to share ROI with their prospective clients? There are things you can do in the interim, especially if you have a good HEOR strategist on board. If you're thoughtful, you may be able to use results from earlier studies to model out potential cost savings. And if you've laid the appropriate groundwork to de-risk your RCT, you can combine the RCT with the HEOR work, reducing timelines and associated costs of separating these steps. #digitalhealth #dtx #research #roi #strategy

🚀 Unlocking Healthcare Insights in 2024: Pharma's Next Big Move! Is unlocking the secrets of healthcare providers' needs and behaviors on your agenda for 2024? You're not alone! A recent EPG Health study identifies this as the top strategic priority for HCP engagement in the upcoming year. 💡 Key Insights: * Pharma's digital landscape is evolving, with 75% reporting progress in their initiatives. * Top priorities for 2024 include HCP insight (57%), enhancing customer experience (47%), and optimizing content for digital consumption (45%). * Challenges persist, notably in demonstrating financial ROI (69%) and showcasing behavioral impact and outcomes (63%). 💡 Challenges in the Digital Realm: * Pharma's digital HCP engagement struggles include demonstrating financial ROI (69%) and behavioral impact and outcomes (63%). * Only 24% comprehensively analyze HCP engagement data, emphasizing a need for change in measurement approaches. 🔍 The Call for Change: Jonathan Macdonald, COO at EPG Health, underscores the need for a transformative approach in measuring impact. "Pharma recognizes there is still a long way to go, particularly around the use of data and understanding the true impact of its engagement activity." 🔗 Read more: Pharma asks 'what’s up, doc?' - Industry seeks to get inside the heads of HCPs in 2024 https://lnkd.in/emmVZUKc 👥 Join the Conversation! How do you envision these trends shaping the pharma landscape in 2024? Share your thoughts! 💬 #HealthcareInsights #PharmaTrends #HCPengagement #DigitalHealthcare

Marketers, CX'rs, and UX'rs, this post is for you--fascinating #BSci insight into consumer behavior and loyalty from Healogix! 🧠💡 Our newest #BSciBite covers research showing that those always seeking the 'best' option ("Maximizers") might actually be less brand loyal? This has huge implications for #healthcare and #pharma, especially for how we... -Segment patients and healthcare consumers -Tailor our communication strategies -Seek to improve treatment adherence -Design more seamless, stress-free patient experiences It's a reminder that understanding psychological nuances and motivational mindsets is key to creating personalized healthcare experiences. One size definitely doesn't fit all! #PatientExperience #ConsumerBehavior #HealthcareInnovation #BehavioralScience

The IQVIA Payer Analytics Suite offers robust analytic capabilities, transforming prescription claim data into actionable insights. Developed specifically for Payers to gain insights across the IQVIA ecosystem of Rx Claims, we provide interactive dashboards to identify and understand opportunities. The Payer Analytic Suite empowers Payers to:   Enhance Health Outcomes and Competitive Edge: ·      Drive insights aimed at improving health outcomes and fostering competitive differentiation.   Understand Member Spend and Utilization: ·      Determine member spend and utilization, both within and outside of Payer Benefits, for a comprehensive understanding of member behavior.   Spot Provider Prescribing Trends and Anomalies: ·      Identify trends and anomalies in provider prescribing patterns, offering valuable insights for decision-making.   Conduct Targeted Analytics on Specialty Drugs: ·      Perform targeted analytics specifically focused on specialty drugs, with the added ability to establish baselines against the broader market landscape.     Our hosted analytics platform ensures rapid access to these insights, eliminating the need for complex integrations or extensive technology setup. It's a streamlined solution designed to empower Payers with the intelligence needed to navigate the complexities of the healthcare landscape effectively. https://lnkd.in/gSw5KMFD

Transforming Healthcare Strategy with Actionable Insights: Discover the expertise of Spade Health, a leading Life Sciences Market Research Company. -We leverage healthcare market research to provide our clients with actionable insights that drive informed decision-making and strategic planning. Through our data-driven approach, we help organizations improve business outcomes and enhance patient experiences in the evolving healthcare landscape. -Healthcare market research is crucial for making informed decisions that enhance business outcomes and enhance patient experiences. In today's era of innovation and digital transformation, healthcare organizations must adapt and strategize wisely to remain relevant and successful in the long run. -it is possible to increase your chances of success in the Life Sciences market by conducting thorough research. Methods such as online focus groups, surveys, customer interviews, and HCP interviews can provide valuable insights into risk tolerance, buying triggers, motivations, and cost sensitivity. . . Planning for Life Sciences Market Research? Request for the quote:email:sales@spaderesearch.com More info visit:https://bit.ly/3XsnlN5 #lifesciencesmarketresearch #lifesciencesresearch #medicaldevicesresearch #lifesciencesresearchcompany #healthmarketresearchservices #healthcaremarketresearch #healthcaresurvey #healthcaresurveycompany